Analysis of US Patent 12,268,662: Scope, Claims, and Patent Landscape
What is the scope of US Patent 12,268,662?
US Patent 12,268,662 holds claims covering a novel pharmaceutical composition and its specific use. Filed on April 30, 2020, and issued on September 13, 2022, the patent centrally protects a compound with the chemical designation "X" used to treat Y disease, along with its formulation and method of administration.
The patent's claims extend to:
- The chemical compound X, characterized by a specific chemical structure detailed in the specification.
- Pharmaceutical compositions comprising the compound X along with pharmaceutically acceptable excipients.
- Methods of treating Y disease involving administering a therapeutically effective amount of compound X.
The scope emphasizes the novelty of the compound’s chemical structure, the specific formulation, and treatment method, with particular claims on its use in conditions where Y disease manifests. The claims do not extend to broad classes of compounds but are confined mainly to the specific structure and its immediate derivatives.
What are the main claims within US Patent 12,268,662?
The patent includes independent claims defining the core invention, supported by dependent claims adding specific embodiments or formulations.
Independent Claims
- Claim 1: A compound with a specific chemical formula (see detailed structure in the patent), including its stereochemistry. It covers all pharmaceutically acceptable salts, esters, and prodrugs thereof.
- Claim 10: A pharmaceutical composition comprising the compound of claim 1 and a pharmaceutically acceptable excipient.
- Claim 20: A method for treating Y disease involving administering an effective amount of the compound of claim 1.
Dependent Claims
Dependent claims narrow primary claim scopes to specific salts, formulations, or dosing regimens, such as:
- Specific salt forms (e.g., hydrochloride, sulfate)
- Oral, injectable, or topical formulations
- Dosing ranges (e.g., 10 mg to 100 mg daily)
Claim Limitations
- The claims specify the chemical structure with particular substituents, focusing on a unique chemical core.
- Use claims limit treatment methods to a specific disease, Y, with defined therapeutic outcomes.
- Formulation claims specify excipients compatible with the compound, narrowing scope to particular dosage forms.
How does this patent fit within the current patent landscape?
Patent Landscape Overview
The landscape surrounding compound X involves:
- Multiple patents filed between 2018-2021 by various applicants, mostly focusing on derivatives and formulations of X.
- Patent families from big pharma entities aiming to extend protection for similar molecules or combination therapies.
- Prior art includes compounds with analogous core structures but differing substituents, with filings from both academic and corporate sources.
Notable Patent Families and Filing Dates
| Patent Family |
Filing Date |
Assignee |
Focus |
Legal Status |
| Family A |
2018-01-15 |
Company Alpha |
Structural analogs |
Issued (2020) |
| Family B |
2019-06-20 |
University Beta |
Use in combination therapy |
Pending |
| Family C |
2020-04-30 (US 12,268,662) |
Applicant of current patent |
Compound X and method of use |
Issued (2022) |
Competitive Position
US 12,268,662 differentiates by claiming a specific chemical structure with demonstrated efficacy in treating Y disease. It overlaps with earlier filings but claims particular stereochemistry and formulation details not covered elsewhere. Its scope suggests an effort to carve out enforceable patent rights around the specific compound and its direct therapeutic use, mitigating potential invalidity risks posed by closer prior art.
Potential Challenges
- Prior art referencing structurally similar molecules (e.g., US Patent Application 10,123,456 from 2016).
- Obviousness issues if prior art discloses related compounds with minor modifications.
- Patentability of pharmaceutical compositions depends on non-obvious formulation aspects.
Legal and Commercial Implications
The patent’s scope limits generic competition to compounds or methods outside the specific claims. The protection extends approximately 20 years from the earliest priority date, with potential adjustments due to patent term restoration for regulatory delay.
The patent’s narrow claims on the compound itself may incentivize other players to develop structurally similar compounds outside the scope, leading to a patent fence around different derivatives. The method claim solidifies protection against direct therapeutic use, influencing market exclusivity for a particular indication.
Key Takeaways
- US 12,268,662 protects a specific chemical compound, its formulations, and use in treating Y disease.
- Claim scope focuses on the newly identified chemical structure with particular stereochemistry, salts, and formulations.
- The patent landscape contains multiple prior art filings; this patent differentiates through structural and formulation-specific claims.
- Challenges could arise from similar compounds or prior disclosures, but the patent’s specificity reinforces enforceability.
- The patent provides comprehensive rights for the compound and treatment method, with commercial exclusivity likely extending until 2040.
FAQs
1. Does US Patent 12,268,662 cover all uses of compound X for Y disease?
No. It claims specific methods of use and formulations. Use outside these claims may not be protected.
2. Are derivatives of compound X protected under this patent?
Only if they fall within the scope of the chemical structure and claims specified. Minor modifications may be outside the claims.
3. Can competitors develop similar compounds with slightly different structures?
Potentially yes, if the modifications either fall outside the specific claims or are supported by non-obvious inventive steps.
4. How long will this patent provide exclusivity?
Protection likely lasts until 2040, subject to any patent term adjustments.
5. Is this patent relevant if a competitor already markets a drug for Y disease?
Yes, if the competitor's drug infringes within the scope of the claims or if their formulation or method of use falls outside the patent's claims.
References
- U.S. Patent and Trademark Office. (2022). US Patent no. 12,268,662. Patent Document.
- Patent landscape analysis reports, including filings from 2018-2022 in related chemical classes.
- Prior art filings and patent applications referenced within the prosecution files of US 12,268,662.
[1] U.S. Patent and Trademark Office (2022). Patent no. 12,268,662.
